Literature DB >> 32322916

Contribution of Interventional Radiology to the Management of COVID-19 patient.

Lorenzo Monfardini1, Claudio Sallemi1, Nicolò Gennaro2, Vittorio Pedicini3, Claudio Bnà1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32322916      PMCID: PMC7176313          DOI: 10.1007/s00270-020-02470-0

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


× No keyword cloud information.
To the Editor, The COVID-19 outbreak is currently spreading throughout northern Italy and is forcing a rapid change of clinical priorities and organizational logistics. In this dramatic scenario, angio-suites and operatory rooms only admit urgent procedures and the interventional radiology (IR) service is mostly dedicated to assisting the emergency department in dealing with SARS-CoV-2-positive patients. We share a case of pleural drainage in one COVID-19 patient and provide the IR community with some practical recommendations regarding the management of this particular category of patients. A 63-year-old woman with metastatic ovarian cancer and recurrent malignant pleural effusion came to our institutional ER with fever (39 °C) and dyspnea at rest. Being our institute located in a severely involved area of the COVID-19 outbreak, clinical symptoms were compatible with COVID-19 infection. Laboratory parameters included hemoglobin 10.7, white blood cells 3.98, C-reactive protein 43.5, arterial pH 7.5, pO2 53 mmHg, pCO2 31 mmHg and blood lactate concentration 1 mmol/L. Although the patient underwent a right pleurodesis 6 months ago, chest X-ray showed bilateral pleural effusion (loculated on the right side) as well as interstitial thickening (Fig. 1A), a common imaging feature in COVID-19. She underwent a naso-/oropharyngeal swab which turned positive for SARS-CoV-2 nucleic acid after being processed through a real-time reverse transcriptase polymerase chain reaction (Novel Coronavirus PCR Fluorescence Diagnostic Kit, BioGerm Medical Biotechnology). She started as an inpatient with 1 week of non-invasive assisted ventilation that reduced fever, clinical symptoms and normalized inflammatory laboratory values such as C-reactive protein. Still, respiratory function and blood oxygen levels remained poor despite an increase in FiO2 from 60 to 70%. Consequently, percutaneous drainage was requested with the aim of improving ventilation and blood oxygen saturation. The procedure was performed at the bedside in an isolated ward dedicated to COVID-19 patients. The operator wore an FFp2 mask, double gloves, protective glasses and a surgical gown (Fig. 2). After local anesthesia, two 8F multi-hole drainages were inserted bilaterally using dedicated US equipment in the isolated ward as image guidance. The procedure lasted approximately 1 h and was well tolerated. Around 1800 mL was drained in the next 5 h from both sides. All disposable equipment and devices were then immediately discarded in specific containers. Post-procedural chest X-rays showed a marked increase in the ventilated parenchyma. Along with clinical symptoms, also laboratory markers rapidly improved and blood saturation levels reached the normal range (SpO2 98%). The patient switched from assisted ventilation to a simple face mask (2 L/min O2) and maintained normal peripheral capillary oxygen saturation. At the time of writing, she is alive and close to hospital discharge.
Fig. 1

A Chest X-ray shows bilateral pleural effusion and diffuse interstitial thickening. B Chest X-ray performed 24 h after bilateral pleural drainages shows nearly complete resolution of the pleural effusions on both sides

Fig. 2

Operator wearing protective equipment before the procedure

A Chest X-ray shows bilateral pleural effusion and diffuse interstitial thickening. B Chest X-ray performed 24 h after bilateral pleural drainages shows nearly complete resolution of the pleural effusions on both sides Operator wearing protective equipment before the procedure The current COVID-19 outbreak is causing a massive overcrowding of admitted patients for symptomatic pneumonia. Patient presentation ranges from mild symptoms to severe respiratory syndrome due to extended parenchymal involvement, especially in the advanced-phase disease (8–14 days after the onset of first symptoms) [1]. Pleural effusion is not typical of COVID-19 infection, but is a common finding in metastatic oncologic patients and may severely impact respiratory function. Whether the infection concurred to the recurrence of the pleural effusion is not known, but pleural effusion in COVID-19 patients has been described as a poor prognosticator of clinical evolution [2]. Being ventilation the first line treatment for COVID-19 patients, pleural drainage is recommended to improve oxygenation. US-guided thoracic interventions like pleural drainage is a safe and practical procedure that can be performed at the bedside with due arrangements for operator’s safety in case of infectious patients [3]. The versatility of US-guided procedures fits well with the need to entail procedures on isolated patients in separate places and times [4]. In fact, the possibility to perform the procedure at the bedside avoids the spread of disease outside the dedicated COVID-19 ward and does not require discontinuation of assisted ventilation. This is not the first time that interventional radiologists have been called to actively contribute to an infectious outbreak. In 2003, the SARS outbreak raised awareness among the IR community about the role of our specialty in such a delicate scenario. Lau et al. [5] proposed decentralization of the service, predilection of US-guided procedures, rigorous triage and strict respect of safety measures as key elements for delivering high-quality IR care. We acknowledge that in this historic moment the overcrowding of the emergency units may hinder multidisciplinary collaboration. However, considering that COVID-19 is a rapidly changing respiratory syndrome with unpredictable clinical evolution, a smooth collaboration between IR and all the health workers involved in the management of COVID-19 patients will be critical in the upcoming months to effectively distribute the workload and timely ensure the best care possible. In conclusion, IR units should be responsive and equipped to deal with COVID-19 outbreak, as they may play a key role in the optimization of patient ventilation through minimally invasive procedures.
  5 in total

1.  Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Authors:  Jin-Jin Zhang; Xiang Dong; Yi-Yuan Cao; Ya-Dong Yuan; Yi-Bin Yang; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-02-27       Impact factor: 13.146

2.  CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China.

Authors:  Shuchang Zhou; Yujin Wang; Tingting Zhu; Liming Xia
Journal:  AJR Am J Roentgenol       Date:  2020-03-05       Impact factor: 3.959

3.  An easier and safe affair, pleural drainage with ultrasound in critical patient: a technical note.

Authors:  Luigi Vetrugno; Giovanni Maria Guadagnin; Daniele Orso; Enrico Boero; Elena Bignami; Tiziana Bove
Journal:  Crit Ultrasound J       Date:  2018-08-01

4.  Old Threat, New Enemy: Is Your Interventional Radiology Service Ready for the Coronavirus Disease 2019?

Authors:  Kun Da Zhuang; Bien Soo Tan; Ban Hock Tan; Chow Wei Too; Kiang Hiong Tay
Journal:  Cardiovasc Intervent Radiol       Date:  2020-02-26       Impact factor: 2.740

Review 5.  Is your interventional radiology service ready for SARS?: The Singapore experience.

Authors:  Te-Neng Lau; Ngee Teo; Kiang-Hiong Tay; Ling-Ling Chan; Daniel Wong; Winston E H Lim; Bien-Soo Tan
Journal:  Cardiovasc Intervent Radiol       Date:  2003 Sep-Oct       Impact factor: 2.740

  5 in total
  1 in total

1.  Transforming Positive Pressure IR Suites to Treat COVID-19 Patients.

Authors:  Nicole A Lamparello; Sarah Choi; Resmi Charalel; Kyungmouk Steve Lee; Andrew Kesselman; Kimberly Scherer; Christopher M Harnain; William F Browne; Marc Shiffman; Daniel J Holzwanger; Bradley B Pua
Journal:  J Vasc Interv Radiol       Date:  2020-06-30       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.